Navigation Links
Sermo Study Shows 63% of Physicians Would Utilize New Gout Treatments
Date:11/5/2010

CAMBRIDGE, Mass., Nov. 5, 2010 /PRNewswire/ -- Sermo (http://www.sermo.com), the world's largest online community for physicians, today announced a free Sermo Report titled, "Treatment Options for Gout". The report gathered feedback from physicians to better understand how they currently treat gout and if they would consider using new treatments.  

While many physicians who participated felt that current gout treatments effectively manage acute and suppressed gout flares, 63% confirmed they would utilize new gout medications as they become available. Physicians also listed many different patient types that would benefit from new gout treatments, including recurrent gouty arthritis, tophaceous gout and those resistant to current treatments.

This free Sermo Report polled 114 physicians across multiple specialties, of which 89% see an average of 19 gout patients per month. Many of the respondents also participated in an online discussion regarding various treatment strategies and how they plan to use newly available therapies.

The full reports includes:

  • Key Findings
  • Physician Demographics
  • Discussion Highlights
  • Quantitative and Qualitative Post Analysis

Companies that are in the process of developing or have approved gout treatments include Takeda Pharmaceuticals, Savient Pharmaceuticals, Cardiome Pharma Corp., Regeneron Pharmaceuticals, Ardea Biosciences and Novartis.

To download full results of this free report, visit sermo.com/client.

About Sermo Reports

Sermo Reports solicit perceptions and opinions from physicians about new drugs, devices, treatments, trends, and other topics of interest. Data for Sermo Reports is
gathered through Sermo Posts, which allow physicians to p
'/>"/>

SOURCE Sermo
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Sermo Report Indicates that Ticagrelor is Likely to Affect the Standard of Care for ACS Patients
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
6. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
7. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
8. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
9. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
10. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
11. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... , Aug. 21, 2014   Royal Philips ... today announced it has received 510(k) clearance from ... its precision planning application for Transcatheter Aortic-Valve Implantation ... application provides interventionalists with pre-procedural, high-precision positioning to ... TAVI planning application is available as part of ...
(Date:8/20/2014)... 2014 Northstar Global Business Services, Inc., ... of hard work from many talented specialists, the ... and package design.  The new formulation for Snorenz ... the product due to overwhelming evidence of increased ... Nighttime will also include these vitamins, as well ...
(Date:8/20/2014)... 2014  The National Association of Drug Diversion ... by the real-time, pseudoephedrine (PSE) blocking system in ... Exchange (NPLEx), automatically blocks unlawful pseudoephedrine sales and ... and make arrests. Data released by NPLEx shows ... blocked the sale of more than 32,890 boxes of ...
Breaking Medicine Technology:Philips receives FDA 510(k) Clearance for TAVI Precision Treatment Planning Application 2Philips receives FDA 510(k) Clearance for TAVI Precision Treatment Planning Application 3Northstar completes the first phase of its new retail strategy and prepares to ship reformulated Snorenz with all new packaging 2Michigan's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
... Sinovac Biotech Ltd. (Amex:,SVA), a leading provider of ... the clinical trials for its pandemic influenza,vaccines. Sinovac ... State Food,and Drug Administration (SFDA) to commence Phase ... whole viron inactivated vaccine and Phase I and,II ...
... Phase I Clinical Trial of Proprietary siRNA Molecule in Acute ... ... 19 Quark Pharmaceuticals, Inc., a,development-stage pharmaceutical company focused on discovering ... dosing in humans of its proprietary product,candidate, AKIi-5, a siRNA compound ...
Cached Medicine Technology:Sinovac Provides Update in Pandemic Influenza Vaccines (H5N1) Phase II Clinical Trials 2Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans 2Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans 3Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans 4
(Date:8/21/2014)... in the coronary arteries of chronic kidney disease patients ... according to a new study in the Journal ... ). Researchers at the Johns Hopkins Bloomberg School of ... commonly used measures of subclinical atherosclerosis in predicting the ... , Approximately 50 percent of all patients with chronic ...
(Date:8/21/2014)... cancer appear to have better survival if they ... Author: Uchechukwu C. Megwalu, M.D., M.P.H., of the ... York, and colleagues. , Background: Approximately 11,000 to ... year and squamous cell carcinoma accounts for the ... total surgical removal of the larynx with postoperative ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 Improv performers ... entertained residents with dementia at Silverado Turtle Creek memory ... which consists of entertainers ranging from ages 10 to ... they perform their 40-minute set. The troupe's philosophy is ... universal and allows them to touch audiences regardless of ...
(Date:8/21/2014)... -- Researchers have pinpointed the environmental source of fungal ... California for decades. It literally grows on trees. , ... a 13-year-old girl, who spent the summer gathering soil ... hit by infections of the fungus named Cryptococcus ... , which encompasses a number of species including ...
(Date:8/21/2014)... The City of Garden Grove is pleased ... for its inaugural “Re:Imagine Garden Grove – A Downtown ... 11 a.m. to 4 p.m., 2.85-miles of Garden Grove ... downtown will be filled with diverse music, dance, interactive ... (CARS), for all to enjoy. , The car-free route ...
Breaking Medicine News(10 mins):Health News:Measuring calcium buildup to predict heart disease in those with chronic kidney disease 2Health News:Surgery associated with better survival for patients with advanced laryngeal cancer 2Health News:Unicorn Clearance Improv Troupe Brings Laughter to Residents with Dementia at Silverado Memory Care 2Health News:Fungus deadly to AIDS patients found to grow on trees 2Health News:"Re:Imagine Garden Grove - A Downtown Open Streets Event" 2Health News:"Re:Imagine Garden Grove - A Downtown Open Streets Event" 3Health News:"Re:Imagine Garden Grove - A Downtown Open Streets Event" 4
... Contract supports U.S. Army,s Stryker medical evacuation vehicle, ... AIRM ), the largest air medical transportation ... has been awarded a contract in,excess of $15 ... for Air Methods to provide more than 300 ...
... Oct. 27 New research published in the ... because the,fruit possesses antimicrobial phytochemicals that suppress growth ... gum disease. The study,was conducted at the College ... a research group led by Christine D. Wu, ...
... 6:00 am PST -- UCB announced,today the ... Research,and Education Foundation (REF) as a Pinnacle sponsor ... for Rheumatoid Arthritis." The,announcement was made at the ... are joining the Within Our Reach program because ...
... review finds it,s an accepted treatment in adults as ... -- Between 1990 and 2002, off-label use of anticancer ... and 33.2 percent, and most of that off-label use ... studies from a number of countries. , In off-label ...
... DALLAS, Oct. 27 From Illinois to California, ... (Connecting About,Real Experiences) to find out about patients, ... visit. Hospitals participating in the initial,launch of this ... IL;,Clovis Community Medical Center in Clovis, CA; HealthONE ...
... ARAY ), a global leader in the field ... present at the 19th,Annual Oppenheimer Healthcare Conference in New ... (7:00 a.m. PST.), A live webcast of the ... of the Company,s Web site at, http://www.accuray.com . The ...
Cached Medicine News:Health News:Air Methods Awarded $15 Million Contract From General Dynamics Land Systems 2Health News:University of Illinois - Chicago Study: Raisins Contain Compounds that May Inhibit Cavity-causing Bacteria 2Health News:UCB Becomes Pinnacle Donor to the American College of Rheumatology Research and Education Foundation's Research Campaign 2Health News:UCB Becomes Pinnacle Donor to the American College of Rheumatology Research and Education Foundation's Research Campaign 3Health News:Most Off-Label Cancer Drug Use for Palliative Care 2Health News:The Beryl Companies Launches CARE Calls Program in Five Hospitals Across U.S. 2Health News:Accuray Incorporated to Speak at Oppenheimer Healthcare Conference 2
... The new Finnpipette Focus from Thermo Labsystems ... uncompromising performance. Advanced features such as ... fine volume adjustment on microvolumes help to ... single channel pipettes. The new interchangeable handle ...
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z71,407-0) or contact custom...
... Finnpipette Digital offers improved ergonomics for ... handle, modified grippy finger rest and ... comfort and efficiency. Finnpipette Digitals also ... gearing mechanism (pat. pend.) and super ...
... Pipetman Ultra is a fully adjustable, air-displacement ... It is the latest member of the ... characteristics: robustness, accuracy, and precision. We also ... feedback from our customers. Eight models cover ...
Medicine Products: